Anika Therapeutics reported $17.99M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 7M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Agenus AGEN:US $ 16.65M 298K
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Anika Therapeutics ANIK:US $ 17.99M 186K
Arrowhead Research ARWR:US $ 17.86M 1.67M
Chemocentryx CCXI:US $ 19.7M 3.44M
Clovis Oncology CLVS:US $ 32.92M 2.98M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Enanta Pharmaceuticals ENTA:US $ 8.48M 151K
Flexion Therapeutics FLXN:US $ 27.41M 189K
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Immunogen IMGN:US $ 9.73M 481K
Insmed INSM:US $ 57.18M 5.63M
Integra Lifesciences IART:US $ 155.99M 10.85M
Intrexon XON:US $ 20M 1.3M
Johnson & Johnson JNJ:US $ 6.07B 641M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Ligand Pharmaceuticals LGND:US $ 14.71M 2.09M
Macrogenics MGNX:US $ 15.23M 198K
Merit Medical Systems MMSI:US $ 91.56M 10.54M
Peregrine Pharmaceuticals PPHM:US $ 4.46M 595K
Rigel Pharmaceuticals RIGL:US $ 22.38M 257K
Sangamo Biosciences SGMO:US $ 16.49M 338K
Stryker SYK:US $ 1.44B 46M
Surmodics SRDX:US $ 7.88M 22K
Veracyte VCYT:US $ 19.91M 639K
Xencor XNCR:US $ 8.86M 637K
Zimmer Biomet Holdings Inc ZBH:US $ 817.4M 47.3M